Symbol
| MAGEL2
| contributors: mct - updated : 20-11-2024
|
HGNC name
| MAGE-like 2
|
HGNC id
| 6814
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in the hippocampus of patients with incipient Alzheimer disease | constitutional
|  
|  
|  
| loss of function
|
leads to the disruption of hypothalamic feeding circuits, an effect that appears to be independent of the neurodevelopmental effects of leptin and ghrelin and likely involves a direct neurotrophic effect of MAGEL2 | |
Variant & Polymorphism
|
| |
Candidate gene
| regulation of normal circadian rhythm |
Marker
Therapy target
| | |
| Magel2-null mice exhibit neonatal growth retardation, excessive weight gain after weaning, and increased adiposity with altered metabolism in adulthood as seen in PWS patients | |
mice lacking Magel2 display increased weight gain with excess adiposity and other defects suggestive of hypothalamic deficiency |
|
paternally Magel2-null mice have reduced embryonic viability but otherwise normal embryonic growth in survivors, followed by post-natal growth retardation and excessive weight gain, recapitulating aspects of the PWS phenotype |